Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147860502> ?p ?o ?g. }
- W3147860502 endingPage "202" @default.
- W3147860502 startingPage "194" @default.
- W3147860502 abstract "Objective To investigate the efficacy of an herbal formula of Bushen Jianpi ( BSJP) combined with sorafenib on hepatocellular carcinoma (HCC) in vitro and in vivo, and to study the underlying mechanisms of action. Methods BSJP, a mixture of 12 raw herbs, was extracted in 70% alcohol/30% water and freeze-dried into a powder. The in vitro effects of BSJP alone, sorafenib alone, and their combination on cell survival, apoptosis, and cell cycle distribution were evaluated in HCC cell lines HCCLM3, HepG2, and SMMC-7721. The expression of B-cell lymphoma-2 (Bcl-2), caspase-3, and caspase-9 in HCCLM3 cells was measured using Western blots after drug administration. The in vivo effects of BSJP and sorafenib were evaluated in a tumor surgical resection model using 4-week old male athymic BALB/c nude mice injected with HCCLM3 cells. Immunohistochemical analysis of tumor tissues was performed to evaluate the effects of BSJP alone, sorafenib alone, and their combination on the expression of caspase-3, caspase-9, and Bcl-2. Results BSJP decreased the survival rate of HCC cell lines, and the combination of BSJP and sorafenib further decreased the survival rate. BSJP significantly promoted cell apoptosis and blocked cell-cycle progression in HCCLM3, HepG2, and SMMC-7721 cells in a dose-dependent manner. Furthermore, the administration of BSJP and sorafenib inhibited the growth of HCCLM3 cell xenografts in nude mice, with no reduction in body weight. In vivo and in vitro experiments showed that BSJP combined with sorafenib could significantly decrease the expression of Bcl-2. Conclusion Our findings suggest that the herbal formula of BSJP is a potential HCC antitumor agent." @default.
- W3147860502 created "2021-04-13" @default.
- W3147860502 creator A5000104063 @default.
- W3147860502 creator A5012040849 @default.
- W3147860502 creator A5014725505 @default.
- W3147860502 creator A5018639126 @default.
- W3147860502 creator A5023016929 @default.
- W3147860502 creator A5032020402 @default.
- W3147860502 creator A5037935776 @default.
- W3147860502 creator A5050490736 @default.
- W3147860502 creator A5051145637 @default.
- W3147860502 creator A5051915881 @default.
- W3147860502 creator A5063412364 @default.
- W3147860502 creator A5074017253 @default.
- W3147860502 creator A5080031897 @default.
- W3147860502 creator A5083862643 @default.
- W3147860502 creator A5086795138 @default.
- W3147860502 creator A5087920969 @default.
- W3147860502 creator A5090765494 @default.
- W3147860502 date "2021-04-01" @default.
- W3147860502 modified "2023-10-17" @default.
- W3147860502 title "Herbal formula of Bushen Jianpi combined with sorafenib inhibits hepatocellular carcinoma growth by promoting cell apoptosis and blocking the cell cycle." @default.
- W3147860502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33825398" @default.
- W3147860502 hasPublicationYear "2021" @default.
- W3147860502 type Work @default.
- W3147860502 sameAs 3147860502 @default.
- W3147860502 citedByCount "4" @default.
- W3147860502 countsByYear W31478605022022 @default.
- W3147860502 countsByYear W31478605022023 @default.
- W3147860502 crossrefType "journal-article" @default.
- W3147860502 hasAuthorship W3147860502A5000104063 @default.
- W3147860502 hasAuthorship W3147860502A5012040849 @default.
- W3147860502 hasAuthorship W3147860502A5014725505 @default.
- W3147860502 hasAuthorship W3147860502A5018639126 @default.
- W3147860502 hasAuthorship W3147860502A5023016929 @default.
- W3147860502 hasAuthorship W3147860502A5032020402 @default.
- W3147860502 hasAuthorship W3147860502A5037935776 @default.
- W3147860502 hasAuthorship W3147860502A5050490736 @default.
- W3147860502 hasAuthorship W3147860502A5051145637 @default.
- W3147860502 hasAuthorship W3147860502A5051915881 @default.
- W3147860502 hasAuthorship W3147860502A5063412364 @default.
- W3147860502 hasAuthorship W3147860502A5074017253 @default.
- W3147860502 hasAuthorship W3147860502A5080031897 @default.
- W3147860502 hasAuthorship W3147860502A5083862643 @default.
- W3147860502 hasAuthorship W3147860502A5086795138 @default.
- W3147860502 hasAuthorship W3147860502A5087920969 @default.
- W3147860502 hasAuthorship W3147860502A5090765494 @default.
- W3147860502 hasConcept C126322002 @default.
- W3147860502 hasConcept C1491633281 @default.
- W3147860502 hasConcept C150903083 @default.
- W3147860502 hasConcept C190283241 @default.
- W3147860502 hasConcept C202751555 @default.
- W3147860502 hasConcept C204232928 @default.
- W3147860502 hasConcept C207001950 @default.
- W3147860502 hasConcept C2778019345 @default.
- W3147860502 hasConcept C2778695046 @default.
- W3147860502 hasConcept C29537977 @default.
- W3147860502 hasConcept C502942594 @default.
- W3147860502 hasConcept C54355233 @default.
- W3147860502 hasConcept C55493867 @default.
- W3147860502 hasConcept C62112901 @default.
- W3147860502 hasConcept C71924100 @default.
- W3147860502 hasConcept C81885089 @default.
- W3147860502 hasConcept C86803240 @default.
- W3147860502 hasConcept C98274493 @default.
- W3147860502 hasConceptScore W3147860502C126322002 @default.
- W3147860502 hasConceptScore W3147860502C1491633281 @default.
- W3147860502 hasConceptScore W3147860502C150903083 @default.
- W3147860502 hasConceptScore W3147860502C190283241 @default.
- W3147860502 hasConceptScore W3147860502C202751555 @default.
- W3147860502 hasConceptScore W3147860502C204232928 @default.
- W3147860502 hasConceptScore W3147860502C207001950 @default.
- W3147860502 hasConceptScore W3147860502C2778019345 @default.
- W3147860502 hasConceptScore W3147860502C2778695046 @default.
- W3147860502 hasConceptScore W3147860502C29537977 @default.
- W3147860502 hasConceptScore W3147860502C502942594 @default.
- W3147860502 hasConceptScore W3147860502C54355233 @default.
- W3147860502 hasConceptScore W3147860502C55493867 @default.
- W3147860502 hasConceptScore W3147860502C62112901 @default.
- W3147860502 hasConceptScore W3147860502C71924100 @default.
- W3147860502 hasConceptScore W3147860502C81885089 @default.
- W3147860502 hasConceptScore W3147860502C86803240 @default.
- W3147860502 hasConceptScore W3147860502C98274493 @default.
- W3147860502 hasIssue "2" @default.
- W3147860502 hasOpenAccess W3147860502 @default.
- W3147860502 hasRelatedWork W1573078005 @default.
- W3147860502 hasRelatedWork W1991910781 @default.
- W3147860502 hasRelatedWork W2003019539 @default.
- W3147860502 hasRelatedWork W2039481576 @default.
- W3147860502 hasRelatedWork W2069723381 @default.
- W3147860502 hasRelatedWork W2081557098 @default.
- W3147860502 hasRelatedWork W2120441162 @default.
- W3147860502 hasRelatedWork W2143133482 @default.
- W3147860502 hasRelatedWork W2353834389 @default.
- W3147860502 hasRelatedWork W2354575037 @default.
- W3147860502 hasRelatedWork W2370141061 @default.
- W3147860502 hasRelatedWork W2580763745 @default.
- W3147860502 hasRelatedWork W2589384660 @default.